Management of Anxiety and ADHD in Children

Initial Assessment and Differential Diagnosis

The American Academy of Child and Adolescent Psychiatry recommends beginning with a comprehensive diagnostic evaluation to differentiate between anxiety disorders, ADHD, or comorbid presentations, as anxiety and ADHD frequently co-occur and require distinct treatment approaches 1, 2
Validated screening instruments such as the Pediatric Symptom Checklist or Strengths and Difficulties Questionnaire should be deployed to systematically identify whether anxiety, attention problems, or both are driving the clinical presentation 3
The AACAP Level 1 Cross-Cutting Symptom Measures can be used to screen across multiple psychiatric domains including anxiety and ADHD simultaneously 3
Anxiety disorders and ADHD co-occur frequently, requiring treatment of both conditions 1, 2

The American Academy of Child and Adolescent Psychiatry recommends cognitive-behavioral therapy (CBT) as the first-line treatment for primary anxiety disorder, delivered over 12-20 structured sessions targeting the cognitive, behavioral, and physiologic dimensions of anxiety 6, 7, 5
CBT components should include psychoeducation, behavioral goal setting, self-monitoring, relaxation techniques, cognitive restructuring, graduated exposure therapy, and family interventions 7
For severe anxiety or when quality CBT is unavailable, selective serotonin reuptake inhibitors (SSRIs) can be offered to children 6-18 years with generalized anxiety, social anxiety, or separation anxiety disorder 7, 5
The American Academy of Child and Adolescent Psychiatry recommends against benzodiazepines for pediatric anxiety due to lack of efficacy data and risk of dependence 4

Standardized symptom rating scales should be used at each visit to systematically track treatment response 3, 5
Functional impairment in social, educational, and family domains should be assessed, not just symptom reduction 6, 2
Monitoring for suicidal ideation is crucial when using SSRIs, with a pooled absolute risk of 1% versus 0.2% with placebo (number needed to harm = 143) 5, 4
Untreated anxiety can lead to significant long-term impairments in social, educational, and mental health outcomes extending into adulthood, making early intervention critical 6, 2